Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Segall Bryant & Hamll Intl Eq Inst CIEQX
- NAV / 1-Day Return 10.94 / −0.28 %
- Total Assets 2.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.990%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Value
- Min. Initial Investment 250,000
- Status Open
- TTM Yield —
- Turnover —
USD | NAV as of May 03, 2024 | 1-Day Return as of May 03, 2024, 12:51 AM GMT+0
Morningstar’s Analysis CIEQX
Will CIEQX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 14.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novartis AG Registered Shares | 2.14 | 52,498 | Healthcare |
ASML Holding NV | 1.82 | 44,591 | Technology |
Shell PLC | 1.62 | 39,681 | Energy |
Novo Nordisk A/S Class B | 1.52 | 37,326 | Healthcare |
GSK PLC | 1.51 | 37,142 | Healthcare |
Honda Motor Co Ltd | 1.28 | 31,464 | Consumer Cyclical |
Roche Holding AG | 1.18 | 29,107 | Healthcare |
Canon Inc | 1.17 | 28,661 | Technology |
Nestle SA | 1.16 | 28,582 | Consumer Defensive |
Volvo AB Class B | 1.12 | 27,503 | Industrials |